Literature DB >> 31397261

Effect of community members' willingness to disclose a mental disorder on their psychiatric symptom scores: analysis of data from two randomised controlled trials of mental health first aid training.

A F Jorm1, A J Mackinnon1,2, L M Hart1, N J Reavley1, A J Morgan1.   

Abstract

AIMS: The prevalence of common mental disorders has not declined in high-income countries despite substantial increases in service provision. A possible reason for this lack of improvement is that greater willingness to disclose mental disorders might have led to increased reporting of psychiatric symptoms, thus masking reductions in prevalence. This masking hypothesis was tested using data from two trials of interventions that increased willingness to disclose and that also measured symptoms. Both interventions involved Mental Health First Aid (MHFA) training, which is known to reduce stigma, including unwillingness to disclose a mental health problem.
METHODS: A cross-lagged panel analysis was carried out on data from two large Australian randomised controlled trials of MHFA training. The first trial involved 1643 high school students in Year 10 (mean age 15.87 years), who were randomised to receive either teen MHFA training or physical first aid training as the control. The second trial involved 608 Australia public servants who were randomised to receive either eLearning MHFA, blended eLearning MHFA or eLearning physical first aid as the control. In both trials, willingness to disclose a mental disorder as described in vignettes and psychiatric symptoms (K6 scale) were measured pre-training, post-training and at 12-month follow-up.
RESULTS: Both trials found that MHFA training increased willingness to disclose. However, a cross-lagged panel analysis showed no effect of this change on psychiatric symptom scores.
CONCLUSIONS: Greater willingness to disclose did not affect psychiatric symptom scores. Because the trials increased willingness to disclose through a randomly assigned intervention, they provide a strong causal test of the masking hypothesis. It is therefore unlikely that changes in willingness to disclose are masking reductions in prevalence in the population.

Entities:  

Keywords:  Adolescents; attitudes; common mental disorders; mental health; stigma

Mesh:

Year:  2019        PMID: 31397261      PMCID: PMC8061127          DOI: 10.1017/S2045796019000404

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


Introduction

Data from a number of high-income countries show that, despite substantial increases in the provision of treatment over time, there has not been any reduction in the prevalence of common mental disorders or psychiatric symptoms (Ormel et al., 2004; Jorm et al., 2017; Mulder et al., 2017; Bastiampillai et al., 2019). Prevalence rates have similarly been stable for children and adolescents, apart from an increase in depression in adolescent girls and possibly in boys (Bor et al., 2014). Jorm et al. (2017) argued that reducing prevalence may require a greater emphasis on the quality of services and on prevention. However, they also considered the hypothesis that a reduction in prevalence produced by services may have been masked by increased reporting of symptoms due to greater public awareness of common mental disorders or reduction in stigma leading to a greater willingness to disclose. At the time of their review, there were no relevant data to test this masking hypothesis. Here we report data from two randomised controlled trials that were used to test the masking hypothesis. Both trials involve Mental Health First Aid (MHFA) courses. These courses train members of the public in how to offer help to a person developing a mental health problem, experiencing a worsening of an existing mental health problem or in a mental health crisis (Jorm et al., 2019). A systematic review and meta-analysis of MHFA trials showed that these courses increase mental health knowledge and reduce stigma (Morgan et al., 2018). Data from the first trial used here were on teen MHFA training of students in Australian high schools (Hart et al., 2018). In a cluster-randomised cross-over design, schools were randomised to receive either teen MHFA or physical first aid. The other dataset was a randomised controlled trial of MHFA training with staff in Australian workplaces, which compared eLearning and blended modes of MHFA (i.e., eLearning combined with a classroom session) with eLearning physical first aid (Reavley et al., 2018). Both trials asked questions about willingness to disclose mental health problems and also measured psychiatric symptoms both before and after training. We analysed these data using cross-lagged panel analysis to test the hypothesis that an increase in willingness to disclose leads to increased reporting of psychiatric symptoms.

Methods

Adolescent MHFA trial

This trial was registered with the Australian New Zealand Clinical Trials Registry (ANZCTRN12614000061639) and the details have been previously reported (Hart et al., 2018). In a cluster-randomised crossover design, four Australian public schools were matched in two pairs and then randomised to either receive teen MHFA or physical first aid for all Year 10 students (mean age 15.87 years). The following year, the new Year 10 cohort received the alternate intervention, giving a total of eight cohorts. Classes comprising 979 students were randomised to teen MHFA and classes with 948 students to physical first aid. Not all students participated in the trial, yielding responses from 1643 individuals. The effects of the training were assessed using online surveys which were administered pre-training, 1-week post-training and at 12-month follow-up. The trial was carried out from 2014 to 2017. There were two outcome measures of relevance to the masking hypothesis. The first was a question asked in relation to vignettes of an adolescent with major depression and suicidal ideation (John) and one with social anxiety disorder (Jeanie). The vignettes (see Appendix) described signs and symptoms consistent with Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnostic criteria, but did not involve any diagnostic labelling of the person's problem. The statement ‘If I had a problem like (John/Jeanie)'s I would not tell anyone’ was rated on a five-point Likert scale ranging from 1 = ‘strongly agree’ to 5 =  ‘strongly disagree’ (Griffiths et al., 2004, 2006; Yap et al., 2014). This question was asked at all three time points. The two vignette ratings at each time point were summed to give a measure of willingness to disclose. The second measure was the K6 psychological distress scale, which asks about symptoms in the previous 30 days (Kessler et al., 2002). This scale was administered pre-training and at follow-up, but not post-training.

Adult MHFA trial

This trial was registered (ACTRN12614000623695) and the details have been previously reported (Reavley et al., 2018). Participants were 608 Australian public servants who were individually randomised to receive either eLearning MHFA (n = 199), blended eLearning MHFA (n = 199) or eLearning physical first aid as the control group (n = 210). For the purposes of the present analysis, both MHFA groups were combined and compared with the control group. Outcomes were assessed by online questionnaire pre-training, post-training and at 12-month follow-up. Again, there were two outcome measures of relevance here. The first was the disclosure question, which was asked in relation to a vignette of an adult with major depression and suicidal thoughts (John) and one with post-traumatic stress disorder (Paula), with the responses summed. As for the adolescent study, the vignettes described signs and symptoms consistent with DSM diagnostic criteria, but did not give any diagnostic label (see Appendix). These disclosure questions were administered at all three time points. The K6 was also administered pre-training and at follow-up. The trial was carried out (up to 12-month follow-up) from 2014 to 2018.

Data analysis

The model fitted to both datasets was a cross-lagged design with additional paths to accommodate the additional assessment of willingness to disclose at an intermediate point between baseline and each trial's endpoint (see Figs 1, 2). The outcomes of both the K6 and willingness to disclose were expected to be substantially determined by the status of each variable earlier in the trial. Principal interest lay in the cross-lagged paths (i.e., the influence of earlier values of willingness to disclose on subsequent K6 scores and vice versa). Supplementary analyses showed the effect of eLearning and blended eLearning MHFA were highly comparable. Accordingly, the effects of the MHFA training intervention were modelled by the inclusion of a single binary indicator (active arm (either MHFA course) = 1; control = 0) with paths to each outcome. Due to randomised assignment to trial group, this variable was specified as being independent of baseline values of the K6 and of willingness to disclose. Model fit was assessed using the Tucker Lewis Index (TLI), Comparative Fit Index (CFI) and the Root Mean Square Error of Approximation (RMSEA). Values of the first two indices greater than 0.95 were taken as demonstrating good fit, as were values of RMSEA <0.06 (Hu and Bentler, 1999). The significance of individual paths and indirect and total effects was assessed using confidence intervals constructed from 10 000 bootstrapped samples. This approach was adopted due to non-normal distributions of the variables in the model and the need to assess the significance of indirect and total effects. Parameters whose 99% confidence intervals excluded zero were considered significant at the equivalent of p < 0.01, while those whose 95% confidence interval excluded zero were deemed significant at p < 0.05. Models were fitted using Mplus version 7.4 (Muthén and Muthén, 1998–2015). With the adolescent MHFA trial, clustering of participants within schools was not accommodated in the model, as this effect was not significant in primary analyses (Hart et al., 2018) and Mplus does not support bootstrapping of clustered samples.
Fig. 1.

Cross-lagged model of willingness to disclose a mental disorder (Disclose) and K6 score in adolescents. (Paths from Group are standardised coefficients for dependent variable only: all others are fully standardised. *: p < 0.05; ** p < 0.01 established from bootstrap confidence intervals.)

Fig. 2.

Cross-lagged model of willingness to disclose mental disorder (Disclose) and K6 score in adults. (Paths from Group are standardised coefficients for dependent variable only: all others are fully standardised. * p < 0.05; ** p < 0.01 established from bootstrap confidence intervals.)

Cross-lagged model of willingness to disclose a mental disorder (Disclose) and K6 score in adolescents. (Paths from Group are standardised coefficients for dependent variable only: all others are fully standardised. *: p < 0.05; ** p < 0.01 established from bootstrap confidence intervals.) Cross-lagged model of willingness to disclose mental disorder (Disclose) and K6 score in adults. (Paths from Group are standardised coefficients for dependent variable only: all others are fully standardised. * p < 0.05; ** p < 0.01 established from bootstrap confidence intervals.)

Results

The model in Fig. 1 was fitted to 1643 participants in this trial. Descriptive statistics for the variables in the model are shown in Table 1. The model provided an excellent fit to the data (χ2 = 7.00, df = 2, p = 0.030; RMSEA = 0.039, p close fit = 0.658; CFI = 0.99, TLI = 0.97).
Table 1.

Descriptive statistics for willingness to disclose and K6 for each occasion of measurement by trial and intervention status

Time 1 Mean (s.d.)Time 2 Mean (s.d.)Time 3 Mean (s.d.)
Adolescent MHFA trial
Willingness to disclose
Control3.51 (0.96) n = 7693.52 (0.98) n = 5603.44 (0.95) n = 409
MHFA3.61 (0.96) n = 7923.89 (0.90) n = 5243.73 (0.88) n = 446
K6 Total score
Control13.82 (5.47) n = 75713.89 (5.28) n = 399
MHFA13.27 (5.23) n = 77813.36 (5.05) n = 433
Adult MHFA trial
Willingness to disclose
Control4.17 (0.75) n = 2104.06 (0.90) n = 774.18 (0.78) n = 83
MHFA4.11 (0.79) n = 3984.33 (0.60) n = 2074.26 (0.72) n = 182
K6 Total score
Control14.02 (5.97) n = 21014.20 (6.35) n = 79
MHFA13.78 (5.79) n = 39813.43 (6.10) n = 181
Descriptive statistics for willingness to disclose and K6 for each occasion of measurement by trial and intervention status Figure 1 shows the expected pattern of substantial and significant effects that earlier values of each variable have on their subsequent status. The inclusion of a direct path from Time 1 to Time 3 values of willingness to disclose led to a significant improvement in fit (Δχ2 = 26.84, df = 1, p < 0.001) and so was retained in the model. Consistent with the mixed model analysis reported previously (Hart et al., 2018), the teen MHFA training led to a significant increase in willingness to disclose at both outcome occasions. The direct effect of training on K6 scores was negligible and non-significant, as was the indirect effect via willingness to disclose at Time 2 (standardised effect: −0.01; 95% CI: −0.02–0.01). Consequently, the overall effect of group on K6 was not significant (see Table 2).
Table 2.

Total effects of baseline status on outcomes in the adolescent MHFA trial

OutcomePredictorStandardised effect95% CI
Willingness to disclose (Time 3)
Willingness to disclose (Time 1)0.40**0.33–0.47
K6 (Time 1)−0.05−0.12–0.02
Group (MHFA v. control)0.14**0.08–0.20
K6 (Time 3)
Willingness to disclose (Time 1)−0.09**−0.15 to −0.03
K6 (Time 1)0.55**0.49–0.60
Group (MHFA v. control)−0.02−0.08–0.02

* p < 0.05; ** p < 0.01.

Total effects of baseline status on outcomes in the adolescent MHFA trial * p < 0.05; ** p < 0.01. Table 2 shows that the total effect of baseline K6 score on willingness to disclose at Time 3 was small and non-significant. However, the direct effect of baseline K6 on willingness to disclose at Time 2 and the indirect effect alone via willingness at Time 2 (standardised effect: −0.04; 95% CI: 0.02–0.07) were both statistically significant. The model developed for the adolescent sample was fitted to data from 608 participants in the adult trial. Descriptive statistics for the variables in the model are shown in Table 1. The model yielded comparable results to the adolescent sample. Once again, model fit was excellent (χ2 = 1.09, df = 2, p = 0.579; RMSEA = 0.000, p close fit = 0.868; CFI = 1.00, TLI = 1.00). As expected, each variable was substantially influenced by its previous value. The direct path from willingness to disclose at baseline to Time 3 was also significant (Δχ2 = 20.61, df = 1, p < 0.001). The effect of intervention group on willingness to disclose was significant at Time 2. The direct effect of the intervention on willingness to disclose at Time 3 was not significant (see Fig. 2) but the total effect, mainly via willingness to disclose at Time 2, was significant (see Table 3). Neither the direct effect of the intervention on the K6 nor the total effect was significant. All cross-lagged effects of baseline K6 and willingness to disclose on each other were small and non-significant.
Table 3.

Total effects of baseline status on outcomes in adult the MHFA trial

OutcomePredictorStandardised effect95% CI
Willingness to disclose (Time 3)
Willingness to disclose (Time 1)0.52**0.40–0.62
K6 (Time 1)0.05−0.06–0.16
Group (MHFA v. control)0.11*0.01–0.22
K6 (Time 3)
Willingness to disclose (Time 1)−0.06−0.15–0.03
K6 (Time 1)0.61**0.49–0.60
Group (MHFA v. control)−0.05−0.14–0.04

* p < 0.05; ** p < 0.01.

Total effects of baseline status on outcomes in adult the MHFA trial * p < 0.05; ** p < 0.01.

Discussion

Both trials found that MHFA training increased willingness to disclose a mental disorder. However, the cross-lagged analysis found no effect of this increase on K6 score in either trial. While willingness to disclose was measured pre-training, post-training and at 12-month follow-up, K6 score was only measured pre-training and at 12-month follow-up. The reason for not also administering the K6 post-training is that the questions refer to the past 4 weeks, which overlaps with the period of the training. It was not thought to be plausible that any change could occur over this time frame. It could be argued that 12 months is too long to wait to assess the impact of changes in willingness to disclose and that ideally there should have been an intermediate measurement point. While an intermediate measure would have been desirable, both trials did find an impact of MHFA training on willingness to disclose at the 12-month follow-up, providing an adequate test of the masking hypothesis. These analyses have a number of strengths. Because the trials increased willingness to disclose through a randomly assigned intervention, they provide a strong causal test of the hypothesis that willingness to disclose increases psychiatric symptom scores. The finding of no link between willingness to disclose and symptom scores is also strengthened by the replication across two different age groups. The sample sizes were also relatively large (1643 and 608 participants), giving good statistical power to detect small effects. However, there are also limitations. The measure of willingness to disclose was brief and consequently had modest reliability. The vignettes also covered a limited range of mental disorders (major depression with suicidal thoughts and social anxiety disorder for adolescents, and major depression with suicidal thoughts and post-traumatic stress disorder for adults). Although the K6 is a well-validated questionnaire, it covers a limited range of symptoms. There could be different results for more stigmatised symptoms (e.g. suicidality, thought disorders). On the other hand, the K6 is an appropriate questionnaire for evaluating the masking hypothesis, because it covers symptoms of the most prevalent mental disorders and there is excellent Australian population data showing no historical change on the K10 (the parent questionnaire of the K6) despite major increases in use of services (Jorm, 2018, 2019). Another limitation is that both trials were carried out in Australia and the findings may not generalise to cultures where the stigma of disclosure is much higher. For example, it has been found that willingness to disclose is lower in Japan than in Australia (Griffiths et al., 2006). It is also possible that the findings could be different where the data were collected orally by an interviewer (as in many prevalence studies) compared to the online self-completion that was used in the current studies. In an interview situation with a stranger, stigmatising attitudes towards disclosure may play a greater role and participants may be more reluctant to report symptoms. Finally, the method used here to test the masking hypothesis assumes that the attitude changes that occur with MHFA training are similar in nature to those that might occur with historical change in the population.

Conclusion

These findings do not support the hypothesis that increases in willingness to disclose mental health problems affect symptom scores. It is therefore unlikely that masking could be responsible for the lack of improvement in the mental health of the population following increased uptake of treatment.
  14 in total

1.  Effect of web-based depression literacy and cognitive-behavioural therapy interventions on stigmatising attitudes to depression: randomised controlled trial.

Authors:  Kathleen M Griffiths; Helen Christensen; Anthony F Jorm; Kimberley Evans; Chloe Groves
Journal:  Br J Psychiatry       Date:  2004-10       Impact factor: 9.319

2.  Has the UK Improving Access to Psychological Therapies programme and rising antidepressant use had a public health impact?

Authors:  Tarun Joseph Bastiampillai; Stephen Allison; Philip Harford; Seth W Perry; Ma-Li Wong
Journal:  Lancet Psychiatry       Date:  2019-03       Impact factor: 27.083

3.  Mental Health First Aid training: lessons learned from the global spread of a community education program.

Authors:  Anthony F Jorm; Betty A Kitchener; Nicola J Reavley
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

4.  Impact of Australia's 'Better Access' scheme on population mental health: Response to commentaries.

Authors:  Anthony F Jorm
Journal:  Aust N Z J Psychiatry       Date:  2019-02-08       Impact factor: 5.744

5.  Australia's 'Better Access' scheme: Has it had an impact on population mental health?

Authors:  Anthony F Jorm
Journal:  Aust N Z J Psychiatry       Date:  2018-10-04       Impact factor: 5.744

6.  Why has increased provision of psychiatric treatment not reduced the prevalence of mental disorder?

Authors:  Roger Mulder; Julia Rucklidge; Sam Wilkinson
Journal:  Aust N Z J Psychiatry       Date:  2017-08-23       Impact factor: 5.744

Review 7.  Are child and adolescent mental health problems increasing in the 21st century? A systematic review.

Authors:  William Bor; Angela J Dean; Jacob Najman; Reza Hayatbakhsh
Journal:  Aust N Z J Psychiatry       Date:  2014-05-14       Impact factor: 5.744

8.  Stigma in response to mental disorders: a comparison of Australia and Japan.

Authors:  Kathleen M Griffiths; Yoshibumi Nakane; Helen Christensen; Kumiko Yoshioka; Anthony F Jorm; Hideyuki Nakane
Journal:  BMC Psychiatry       Date:  2006-05-23       Impact factor: 3.630

Review 9.  Systematic review and meta-analysis of Mental Health First Aid training: Effects on knowledge, stigma, and helping behaviour.

Authors:  Amy J Morgan; Anna Ross; Nicola J Reavley
Journal:  PLoS One       Date:  2018-05-31       Impact factor: 3.240

10.  Helping adolescents to better support their peers with a mental health problem: A cluster-randomised crossover trial of teen Mental Health First Aid.

Authors:  Laura M Hart; Amy J Morgan; Alyssia Rossetto; Claire M Kelly; Andrew Mackinnon; Anthony F Jorm
Journal:  Aust N Z J Psychiatry       Date:  2018-02-08       Impact factor: 5.744

View more
  1 in total

1.  Trends in Primary Mental Health Care Service Use and Subsequent Self-Harm in Western Sydney Australia: Policy and Workforce Implications.

Authors:  Sithum Munasinghe; Andrew Page; Sandro Sperandei; Pankaj Gaur; Shahana Ferdousi; Haider Mannan; Vlasios Brakoulias
Journal:  Int J Environ Res Public Health       Date:  2022-03-13       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.